RICHMOND PHARMACOLOGY LIMITED
Get an alert when RICHMOND PHARMACOLOGY LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Cash
£1.1M
+206.2% highest in 3 filed years
Net assets
£7.1M
+11.7% highest in 3 filed years
Employees
207
+7.3% vs 2024
Profit before tax
-£484K
-147.7% vs 2024
Net assets
3-year trend · vs Industrials median
Accounts
3-year trend · Δ = latest vs prior filed period · latest reflected 2025-12-31
| Metric | Trend | 2023-12-31 | 2024-12-31 | 2025-12-31 | Δ vs prior |
|---|---|---|---|---|---|
| Turnover | £23,188,143 | £21,745,142 | £23,473,190 | +7.9% | |
| Operating profit | -£490,914 | £1,209,807 | -£299,552 | -124.8% | |
| Profit before tax | -£728,251 | £1,015,233 | -£484,015 | -147.7% | |
| Net profit | -£1,342,702 | £268,965 | £741,103 | +175.5% | |
| Cash | £417,641 | £350,592 | £1,073,381 | +206.2% | |
| Total assets less current liabilities | £9,137,452 | £9,004,075 | £10,507,332 | +16.7% | |
| Net assets | £6,054,367 | £6,323,332 | £7,064,435 | +11.7% | |
| Equity | £6,054,367 | £6,323,332 | £7,064,435 | +11.7% | |
| Average employees | 218 | 193 | 207 | +7.3% | |
| Wages | £10,671,766 | £9,367,630 | £10,909,708 | +16.5% | |
| Directors' remuneration | £922,750 | £838,474 | £789,730 | -5.8% |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. The Δ column is the change from the prior filed period as a percentage of |prior|; lines a company doesn't report show —. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|---|
| Operating margin | -2.1% | 5.6% | -1.3% | |
| Net margin | -5.8% | 1.2% | 3.2% | |
| Return on capital employed | -5.4% | 13.4% | -2.9% | |
| Current ratio | 1.43x | 1.56x | 1.95x | |
| Interest cover | -1.84x | 4.65x | -1.32x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Auditor
- RSM UK Audit LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.”
Group structure
- RICHMOND PHARMACOLOGY LIMITED · parent
- Prefect Limited 100%
- Richmond Pharmaceutical Services Limited 100%
- Richmond Pharmacology GmBH 100%
Significant events
- “A charge dated 27 March 2024 was created in the form of fixed and floating charges over all the property or undertaking of the company in favour of Barclays Bank PLC. This charge contains a negative pledge.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
3 active · 11 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| BROGHAMMER, Martin | Director | 2022-02-23 | Apr 1960 | German |
| LORCH, Christa Ulrike, Dr | Director | 2001-08-13 | Dec 1964 | German |
| TAUBEL, Jorg, Dr | Director | 2002-01-01 | Jan 1960 | German |
Show 11 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| AREZINA, Radivoj, Dr | Secretary | 2001-08-13 | 2016-05-17 |
| SWIFT INCORPORATIONS LIMITED | Corporate Nominee Secretary | 2001-08-13 | 2001-08-13 |
| AREZINA, Radivoj, Dr | Director | 2001-08-13 | 2016-05-17 |
| BERELOWITZ, Keith Sean | Director | 2016-05-17 | 2024-10-10 |
| LEVINE, Larry | Director | 2002-03-01 | 2010-07-15 |
| LEVINE, Milton Zevi | Director | 2002-03-01 | 2010-07-15 |
| MAGNESS, Peter Richard | Director | 2005-04-28 | 2007-07-09 |
| PRICHARD, Brian Norman Christopher, Professor | Director | 2002-08-08 | 2010-04-06 |
| STIEFEL, Barry Abraham | Director | 2016-05-17 | 2024-10-09 |
| VAUGHAN, Mark Andrew | Director | 2007-07-10 | 2013-05-20 |
| INSTANT COMPANIES LIMITED | Corporate Nominee Director | 2001-08-13 | 2001-08-13 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Ms Christa Ulrike Lorch | Individual | Shares 25–50% | 2016-11-29 | Active |
| Dr. Jorg Taubel | Individual | Shares 25–50% | 2016-11-29 | Active |
Filing timeline
Last 20 of 74 total filings
Material constitutional events — rename, articles re-file, resolution
- 2024-03-15 RESOLUTIONS Resolution
- 2022-02-14 RESOLUTIONS Resolution
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-06-02 | AA | accounts | Accounts with accounts type full | |
| 2025-12-23 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-06-06 | AA | accounts | Accounts with accounts type full | |
| 2024-12-23 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2024-10-10 | TM01 | officers | Termination director company with name termination date | |
| 2024-10-10 | TM01 | officers | Termination director company with name termination date | |
| 2024-07-22 | AA | accounts | Accounts with accounts type full | |
| 2024-03-28 | MR01 | mortgage | Mortgage create with deed with charge number charge creation date | |
| 2024-03-15 | RESOLUTIONS | resolution | Resolution | |
| 2024-02-21 | SH01 | capital | Capital allotment shares | |
| 2023-12-12 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-07-31 | AA | accounts | Accounts with accounts type full | |
| 2022-12-06 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2022-07-06 | AA | accounts | Accounts with accounts type full | |
| 2022-03-18 | AP01 | officers | Appoint person director company with name date | |
| 2022-02-14 | RESOLUTIONS | resolution | Resolution | |
| 2022-02-14 | SH08 | capital | Capital name of class of shares | |
| 2021-12-13 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2021-09-09 | MR04 | mortgage | Mortgage satisfy charge full | |
| 2021-09-07 | MR04 | mortgage | Mortgage satisfy charge full |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 2
- Capital events
- 0
- Officers appointed
- 0
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.